. home.aspx

NEWS

home.aspx
   


Bayer, Loxo link in $1.55bn cancer drugs deal

November 15, 2017 / Selina McKee
SHARESHARESHARE

Bayer and Loxo Oncology have agreed to work together on the development and commercialization of two novel cancer therapies, in a deal potentially worth more than $1.5 billion to the latter firm.